The Norwegian Complement Research Group is a dynamic research group with a long and highly-cited track record. The group is led by Professor Tom Eirik Mollnes, MD and two emerging Principle Investigators Per H. Nilsson, MSc, Ph.D. and Soeren Erik Pischke, MD, Ph.D. (certified specialist in Anaesthesiology and Critical care) at the Department of Immunology, the University of Oslo, Institute of Clinical Medicine, Oslo, Norway.
We now have three positions available in our expanding group preferably from September 1, 2018:
- A three-year Post-Doctoral Research Fellowship (SKO 1352) under the supervision of Per H. Nilsson. The topic is host response to biomaterial surfaces, and focus is acute inflammatory (innate immunity) and thrombotic responses when human whole blood faces an artificial surface.
- A two-year Post-Doctoral Research Fellowship (SKO 1352) under the supervision of Soeren E. Pischke with the main aim to pave the way to clinical trials of innate immune system inhibition with newly developed complement and CD14 inhibitors in ischemia/reperfusion injury clinical settings.
- A three-year Ph.D. Research Fellowship position (SK 1017) under the supervision of Soeren E. Pischke where the successful candidate will work on a project studying interaction of danger associated molecular patterns (DAMPs) released of damaged cells in the course of ischemia/reperfusion injury and the innate immune system.
Deadline: June 17, 2018
Αναλυτικές πληροφορίες: researchgate.net